Posts

©aquir / 123RF Stock Photo

FDA approved rucaparib for maintenance treatment of recurrent ovarian, fallopian tube, or primary peritoneal cancer

6th April 2018/0 Comments/in US FDA Onc\Haem Approvals /by News Feed

 

• FDA approved rucaparib for maintenance treatment of recurrent ovarian, fallopian tube, or primary peritoneal cancer. More Information.

https://medi-paper.com/wp-content/uploads/2018/05/1526019381_US-FDA-Oncology-Haematology-Drug-Approvals-e1537929554681.jpg 1000 1495 News Feed https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png News Feed2018-04-06 14:16:202018-05-11 14:21:28FDA approved rucaparib for maintenance treatment of recurrent ovarian, fallopian tube, or primary peritoneal cancer